Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer

Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer

Bibliographic Details
Main Authors:	Li, Na, Sun, Chaoyang, Zhou, Bo, Xing, Hui, Ma, Ding, Chen, Gang, Weng, Danhui
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085066/

Similar Items

The Role of BRCA Status on the Prognosis of Patients with Epithelial Ovarian Cancer: A Systematic Review of the Literature with a Meta-Analysis
by: Sun, Chaoyang, et al.
Published: (2014)

New developments in the anti-neoplastic drug management of ovarian cancer
by: Markman, Maurie
Published: (2013)

miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1
by: SUN, CHAOYANG, et al.
Published: (2013)

Quercetin-induced cardioprotection against doxorubicin cytotoxicity
by: Chen, Jing-Yi, et al.
Published: (2013)

Synthesis, Characterization and Cytotoxicity of Alkylated Quercetin Derivatives
by: Bao, Xin-Ran, et al.
Published: (2016)

New anti-neoplastic drug test using in vitro model: what to be concern?
by: Wiwanitkit, Viroj
Published: (2012)

Neoplastic and nonneoplastic ovarian masses: Diagnosis on cytology
by: Khan, Nazoora, et al.
Published: (2009)

Diazoxide preconditioning antagonizes cytotoxicity induced by epileptic seizures★
by: Fu, Qingxi, et al.
Published: (2013)

On/off-switchable anti-neoplastic nanoarchitecture
by: Patra, Hirak K., et al.
Published: (2015)

Data for induction of cytotoxic response by natural and novel quercetin glycosides
by: Haskins, Alexis H., et al.
Published: (2015)

Quercetin-Imprinted Nanospheres as Novel Drug Delivery Devices
by: Curcio, Manuela, et al.
Published: (2012)

AB170. Quercetin inhibits angiogenesis through thrombospondin-1 up-regulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo
by: Yang, Feiya, et al.
Published: (2016)

Quercetin and ovarian cancer: An evaluation based on a systematic review
by: Parvaresh, Arefe, et al.
Published: (2016)

Antimicrobial activity of 21 anti-neoplastic agents.
by: Hamilton-Miller, J. M.
Published: (1984)

Anti-neoplastic properties of hydralazine in prostate cancer
by: Graça, Inês, et al.
Published: (2014)

QUANTITATIVE STUDIES OF THE SENSITIVITY OF NORMAL AND NEOPLASTIC MOUSE CELLS TO THE CYTOTOXIC ACTION OF ISOANTIBODIES
by: Möller, Erna, et al.
Published: (1962)

Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro virus activity
by: dos Santos, Alda E, et al.
Published: (2014)

Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs
by: Potuckova, Eliska, et al.
Published: (2014)

Potentiation of Anticancer Drugs: Effects of Pentoxifylline on Neoplastic Cells
by: Barancik, Miroslav, et al.
Published: (2011)

Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium
by: Choi, Kyung-Chul, et al.
Published: (2003)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
by: Ryland, Georgina L., et al.
Published: (2015)

Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3)
by: Coyne, CP, et al.
Published: (2013)

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells
by: WANG, YIFEI, et al.
Published: (2015)

MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine
by: Pettifer, Kathleen M., et al.
Published: (2007)

EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism
by: Modernelli, Alice, et al.
Published: (2015)

Histamine receptor antagonism and anti-tumour activity.
by: Collins, M., et al.
Published: (1982)

Assessment of Anti-Cytogenotoxic Effects of Quercetin in Animals Treated with Topotecan
by: Bakheet, Saleh A.
Published: (2011)

Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles
by: Xu, Guangya, et al.
Published: (2015)

Treatment with Panax Ginseng Antagonizes the Estrogen Decline in Ovariectomized Mice
by: Xu, Ying, et al.
Published: (2014)

Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro
by: Jiao Wang, et al.
Published: (2018-06-01)

The role of the sFRP4 protein in modulation of cancer growth and anti-neoplastic drug sensitivity
by: Perumal, Vanathi
Published: (2014)

Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway.
by: Chen Li, et al.

Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway
by: Li, Chen, et al.
Published: (2016)

Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.
by: Hall, I H, et al.
Published: (1994)

The Efficacy of Quercetin in Cardiovascular Health
by: Ward, Natalie, et al.
Published: (2015)

Quercetin and Cancer Chemoprevention
by: Gibellini, Lara, et al.
Published: (2011)

Docking Of Different Enzymes With Quercetin
by: Ng, Pei Ling, et al.
Published: (2003)

Quercetin, Inflammation and Immunity
by: Li, Yao, et al.
Published: (2016)

Role of Quercetin in Modulating Chloride Transport in the Intestine
by: Yu, Bo, et al.
Published: (2016)

Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS
by: Yang, Le-Le, et al.
Published: (2016)